Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Thompson A, Carroll K, A Inker L, Floege J, et al. Clin J Am Soc Nephrol 2019;14:469-481.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thompson A, Carroll K, A Inker L, Floege J, et al. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Clin J Am Soc Nephrol 2019;14:469-481.
PMID: 30635299